TransMedics CCO reports 7,975 RSUs in Form 3/A

TransMedics Group, Inc. filed an amended insider ownership report for Chief Commercial Officer Giovanni Cecere.

Accepted by SEC EDGAR 02/20/2026 - 04:05 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

TransMedics Group, Inc. filed an amended insider ownership report for Chief Commercial Officer Giovanni Cecere. The filing shows he beneficially holds 7,975 restricted stock units (RSUs), each representing a contingent right to receive one share of TransMedics common stock.

These RSUs are reported as directly owned and reflect an equity award rather than an open-market stock purchase or sale. The disclosure updates the market on Cecere’s initial equity-based holdings in the company.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Cecere Giovanni

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Holding	Common Stock	--	--	--

Holdings: Common Stock — 7,975 shares (Direct)

Footnotes (1)

1. F1. Includes 7,975 restricted share units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TransMedics Group (TMDX) Form 3/A filing report for Giovanni Cecere?

The Form 3/A reports Chief Commercial Officer Giovanni Cecere’s initial equity holdings, disclosing 7,975 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of TransMedics Group common stock, reflecting an equity award, not an open-market trade.

How many TransMedics Group (TMDX) shares does Giovanni Cecere’s RSU award represent?

Giovanni Cecere’s award represents 7,975 restricted stock units (RSUs), with each RSU corresponding to one potential share of common stock. If all RSUs vest and settle in stock, the award would deliver 7,975 TransMedics Group common shares to him.

Are there any stock purchases or sales in the TransMedics Group (TMDX) Form 3/A?

The Form 3/A does not show stock purchases or sales. It reports holdings of 7,975 restricted stock units (RSUs) by Chief Commercial Officer Giovanni Cecere, reflecting an equity award position rather than a market transaction in TransMedics Group common stock.

What is the significance of restricted stock units (RSUs) in the TMDX Form 3/A filing?

The filing explains that the 7,975 RSUs each represent a contingent right to receive one share of TransMedics common stock. RSUs are a form of equity compensation that can convert into actual shares if specified vesting conditions are satisfied over time.

Is Giovanni Cecere’s ownership in TransMedics Group (TMDX) reported as direct or indirect?

Cecere’s holdings are reported as direct ownership of 7,975 restricted stock units. The filing does not attribute the RSUs to any trust, partnership, or separate entity, indicating the award is held in his name as Chief Commercial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cecere Giovanni

(Last) (First) (Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER MA 01810

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/14/2025

3. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
02/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,975	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 7,975 restricted share units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Remarks:

This filing is amended to include 7,975 shares in order to correct the inadvertent underreporting of shares held when the Form 3 was filed.

	By: /s/ Gerardo Hernandez, Attorney-in-Fact	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.